Best practice portal main page

Tratamiento de sustitución de opiáceos (TSO) para mejorar el tratamiento antirretroviral en consumidores de opiáceos seropositivos

Summary of the evidence

Rating: Posiblemente beneficioso

El tratamiento de sustitución de opiáceos resultó suficientemente soportado por la evidencia en una síntesis de 4 revisiones narrativas (Malta et al., 2008; OMS, 2007b, Tilson et al., 2007, Lucas et al., 2006, citado en EMCDDA-ECDC 2011) en:

  • mejorar la efectividad del tratamiento antirretroviral en los consumidores de opiáceos seropositivos.

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option

  • Tratamiento farmacológico

Desired outcome(s)

  • reducir las enfermedades infecciosas

Area(s)

  • Reducción de daños

Specific substance or pattern of use

  • opiáceos

Target group(s) or setting(s)

  • UDVP- usuarios de drogas por vía parenteral

References

Evidence database

Explore all resources in the Best practice portal

 

Briefings

A one-stop-shop for anyone planning or delivering health and social responses.

 

Implementation

Implementation inventories including Xchange, Healthy Nightlife Toolbox, EUPC and EIB

 

Evidence

All of the latest research and evidence on drug-related interventions.

 

Standards

Standards and guidelines for drug-related interventions, aimed at improving their quality.

About the Best practice portal

Collaborations and partnerships in best practice

Logo of the Cochrane Collaboration
Logo of the Campbell Collaboration
Grade logo
WHO logo
Top